312 related articles for article (PubMed ID: 32605558)
21. Cardiovascular disease in patients with systemic autoimmune diseases: The relationship between self-perceived risk and actual risk.
Sieiro Santos C; Oliveira MM; Solari PN; Mateus P; Santos MJ; Corominas H; Castro CÁ; Álvarez ED
Reumatol Clin (Engl Ed); 2024 May; 20(5):229-236. PubMed ID: 38880551
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
[TBL] [Abstract][Full Text] [Related]
23. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis.
Kilic G; Kilic E; Akgul O; Ozgocmen S
Int J Rheum Dis; 2016 Apr; 19(4):405-11. PubMed ID: 24283757
[TBL] [Abstract][Full Text] [Related]
24. Increased levels of sirtuin-1 in systemic lupus erythematosus.
Yang C; Li R; Xu WD; Huang AF
Int J Rheum Dis; 2022 Aug; 25(8):869-876. PubMed ID: 35644944
[TBL] [Abstract][Full Text] [Related]
25. Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis.
Avouac J; Koumakis E; Toth E; Meunier M; Maury E; Kahan A; Cormier C; Allanore Y
Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1871-8. PubMed ID: 22730393
[TBL] [Abstract][Full Text] [Related]
26. Osteoporosis in rheumatoid arthritis and ankylosing spondylitis.
Vosse D; de Vlam K
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S62-7. PubMed ID: 19822048
[TBL] [Abstract][Full Text] [Related]
27. Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases.
Aaramaa HK; Mars N; Helminen M; Kerola AM; Palomäki A; Eklund KK; Gracia-Tabuenca J; Sinisalo J; FinnGen ; Isomäki P
Semin Arthritis Rheum; 2024 Apr; 65():152382. PubMed ID: 38308930
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory rheumatic disorders and bone.
Bultink IE; Vis M; van der Horst-Bruinsma IE; Lems WF
Curr Rheumatol Rep; 2012 Jun; 14(3):224-30. PubMed ID: 22477520
[TBL] [Abstract][Full Text] [Related]
29. Metabolic syndrome in rheumatological diseases.
Pereira RM; de Carvalho JF; Bonfá E
Autoimmun Rev; 2009 Mar; 8(5):415-9. PubMed ID: 19168158
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and risk factors for bone loss in rheumatoid arthritis patients from South China: modeled by three methods.
Hu Z; Zhang L; Lin Z; Zhao C; Xu S; Lin H; Zhang J; Li W; Chu Y
BMC Musculoskelet Disord; 2021 Jun; 22(1):534. PubMed ID: 34118911
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of serum connective tissue growth factor in rheumatoid arthritis.
Ren J; Sun L; Sun X; Ma Z; Wang X; An Z; Zhao J
Clin Rheumatol; 2021 Jun; 40(6):2203-2209. PubMed ID: 33389316
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study.
Dai SM; Han XH; Zhao DB; Shi YQ; Liu Y; Meng JM
J Rheumatol; 2003 Oct; 30(10):2245-51. PubMed ID: 14528524
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic immunopathology of the kidney biopsy in rheumatic diseases.
Barba L; Pawlowski I; Brentjens JR; Andres GA
Hum Pathol; 1983 Apr; 14(4):290-304. PubMed ID: 6219934
[TBL] [Abstract][Full Text] [Related]
34. Disease Damage Accrual and Low Bone Mineral Density in Female Patients with Systemic Lupus Erythematosus.
Correa-Rodríguez M; Pocovi-Gerardino G; Callejas-Rubio JL; Ríos-Fernández R; Rueda-Medina B; Ortego-Centeno N
Biol Res Nurs; 2021 Oct; 23(4):575-583. PubMed ID: 33787331
[TBL] [Abstract][Full Text] [Related]
35. Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus.
Zhu L; Zhang J; Wang J; Lv X; Pu D; Wang Y; Men Q; He L
Lupus; 2021 Jun; 30(7):1116-1123. PubMed ID: 33832361
[TBL] [Abstract][Full Text] [Related]
36. Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density.
Pineau CA; Urowitz MB; Fortin PJ; Ibanez D; Gladman DD
Lupus; 2004; 13(6):436-41. PubMed ID: 15303570
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences.
Chou CT; Pei L; Chang DM; Lee CF; Schumacher HR; Liang MH
J Rheumatol; 1994 Feb; 21(2):302-6. PubMed ID: 8182641
[TBL] [Abstract][Full Text] [Related]
38. Cortical thinning and progressive cortical porosity in female patients with systemic lupus erythematosus on long-term glucocorticoids: a 2-year case-control study.
Zhu TY; Griffith JF; Qin L; Hung VW; Fong TN; Au SK; Tang XL; Kun EW; Kwok AW; Leung PC; Li EK; Tam LS
Osteoporos Int; 2015 Jun; 26(6):1759-71. PubMed ID: 25736166
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic disease in the autoimmune rheumatic disorders.
Watts RA; Isenberg DA
Semin Arthritis Rheum; 1989 Dec; 19(3):158-65. PubMed ID: 2690344
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
